Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010 (scientific article)

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

Q30357784

Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination.

Q30379529

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Q30380575

Response to a monovalent 2009 influenza A (H1N1) vaccine.

Q30380581

A novel influenza A (H1N1) vaccine in various age groups.

Q30381838

Estimating influenza vaccine effectiveness using routinely collected laboratory data.

Q30382480

Australia's winter with the 2009 pandemic influenza A (H1N1) virus.

Q30382871

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Q30384762

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada

Q30388012

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

Q30389024

Comparative epidemiology of pandemic and seasonal influenza A in households

Q30390467

Protective effect of single-dose adjuvanted pandemic influenza vaccine in children

Q30391363

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter

Q30393480

Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study

Q30394200

Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.

Q30398764

Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.

Q30399830

Estimation of influenza vaccine effectiveness from routine surveillance data

Q33424462

Field evaluation of vaccine efficacy

Q34193122

Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls

Q34215438

Time lines of infection and disease in human influenza: a review of volunteer challenge studies

Q34743132

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications

Q35013711

Assessing vaccine efficacy in the field. Further observations

Q39560755

Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.

Q44731081

Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain

Q45792636

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

Q46159620

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

Q48071872

Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks

Q50129178

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

Q50801938

What Does the Odds Ratio Estimate in a Case-Control Study?

Q57153184

A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial

Q64130207

Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season

Q83152060

Recommended composition of influenza virus vaccines for use in the 2010 influenza season (southern hemisphere winter)

Q84685526

P433

issue

P921

main subject

Australia

pandemic

influenza vaccine

page(s)

1181-1187

P577

publication date

2011-07-01

P1433

published in

Emerging Infectious Diseases

Q5235761

P1476

title

Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010

P478

volume

Reverse relations

cites work (P2860)

Q33779681	2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network
Q43476703	A retrospective survey of the safety of trivalent influenza vaccine among adults working in healthcare settings in south metropolitan Perth, Western Australia, in 2010.
Q30417900	Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom
Q30352552	Continued dominance of pandemic A(H1N1) 2009 influenza in Victoria, Australia in 2010
Q30235245	Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis
Q30357697	Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study.
Q30426206	Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season
Q30367263	Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland.
Q39438313	Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment
Q30428316	Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study
Q34550913	Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan
Q30354921	Evaluation of the Effectiveness of Pandemic Influenza A(H1N1) 2009 Vaccine Based on an Outbreak Investigation During the 2010-2011 Season in Korean Military Camps
Q30210612	Hospital capacity and management preparedness for pandemic influenza in Victoria.
Q34639535	Impact of preventive responses to epidemics in rural regions
Q30413786	Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.
Q36115609	Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine
Q56791503	Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza
Q34850986	Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study
Q36783905	Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings
Q42187912	Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.
Q38408870	Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.
Q41045747	Influenza vaccines differentially regulate the interferon response in human dendritic cell subsets.
Q44243917	Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.
Q39813068	Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.
Q34778408	Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review
Q30383722	Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach
Q37336804	Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques
Q90692852	The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology
Q38275284	Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia
Q45760952	Variable definitions of the influenza season and their impact on vaccine effectiveness estimates
Q38803189	Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Q30354918	Was the mass vaccination effective during the influenza pandemic 2009-2010 in Korea?
Q37034475	What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins